432 related articles for article (PubMed ID: 17893757)
21. Multidrug-resistant urinary tract isolates of Escherichia coli: prevalence and patient demographics in the United States in 2000.
Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
Antimicrob Agents Chemother; 2001 May; 45(5):1402-6. PubMed ID: 11302802
[TBL] [Abstract][Full Text] [Related]
22. [Antimicrobial resistance profiles of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in Istanbul].
Ozyurt M; Haznedaroğlu T; Sahiner F; Oncül O; Ceylan S; Ardiç N; Erdemoğlu A
Mikrobiyol Bul; 2008 Apr; 42(2):231-43. PubMed ID: 18697421
[TBL] [Abstract][Full Text] [Related]
23. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
[TBL] [Abstract][Full Text] [Related]
24. Multi-drug resistance of Escherichia coli from the urinary tract.
Rafay AM; Nsanze HN
Saudi Med J; 2003 Mar; 24(3):261-4. PubMed ID: 12704500
[TBL] [Abstract][Full Text] [Related]
25. In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood.
Ko KS; Suh JY; Peck KR; Lee MY; Oh WS; Kwon KT; Jung DS; Lee NY; Song JH
Diagn Microbiol Infect Dis; 2007 May; 58(1):111-5. PubMed ID: 17300900
[TBL] [Abstract][Full Text] [Related]
26. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
[TBL] [Abstract][Full Text] [Related]
27. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections.
Schito GC; Naber KG; Botto H; Palou J; Mazzei T; Gualco L; Marchese A
Int J Antimicrob Agents; 2009 Nov; 34(5):407-13. PubMed ID: 19505803
[TBL] [Abstract][Full Text] [Related]
28. Activity of ertapenem and other antimicrobials against ESBL-producing enterobacteria isolated from urine in patients from Madrid.
Tamayo J; Orden B; Cacho J; Cuadros J; Gomez-Garces JL; Alos JI
Rev Esp Quimioter; 2007 Sep; 20(3):334-8. PubMed ID: 18080031
[TBL] [Abstract][Full Text] [Related]
29. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
[TBL] [Abstract][Full Text] [Related]
30. [Community-acquired urinary tract infections in 15 to 65 years old female patients in France. Susceptibility of E. coli according to history: AFORCOPI-BIO network 2003].
de Mouy D; Fabre R; Cavallo JD; Arzouni JP; Baynat M; Bicart-See A; Berges JL; Bouilloux JP; Galinier JL; Garrabé E; Gontier P; Grillet N; Lepargneur JP; Naepels I; Payro G;
Med Mal Infect; 2007 Sep; 37(9):594-8. PubMed ID: 17258415
[TBL] [Abstract][Full Text] [Related]
31. [Susceptibility of Escherichia coli strains isolated from persons with urinary tract infections in 2007 - 2008 to antimicrobial agents].
Kot B; Wicha J; Zak-Puławska Z
Przegl Epidemiol; 2010; 64(2):307-12. PubMed ID: 20731243
[TBL] [Abstract][Full Text] [Related]
32. Co-trimoxazole and quinolone resistance in Escherichia coli isolated from urinary tract infections over the last 10 years.
Karaca Y; Coplu N; Gozalan A; Oncul O; Citil BE; Esen B
Int J Antimicrob Agents; 2005 Jul; 26(1):75-7. PubMed ID: 15955672
[TBL] [Abstract][Full Text] [Related]
33. Risk factors of ciprofloxacin resistance in urinary Escherichia coli isolates.
Lin CY; Huang SH; Chen TC; Lu PL; Lin WR; Chen YH
J Microbiol Immunol Infect; 2008 Aug; 41(4):325-31. PubMed ID: 18787740
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and antimicrobial susceptibility of Escherichia coli in outpatient urinary isolates in Izmir, Turkey.
Yilmaz N; Agus N; Yurtsever SG; Pullukcu H; Gulay Z; Coskuner A; Kose S; Aydemir S; Gulenc N; Ozgenc O
Med Sci Monit; 2009 Nov; 15(11):PI61-5. PubMed ID: 19865064
[TBL] [Abstract][Full Text] [Related]
35. Temporal changes in the prevalence of community-acquired antimicrobial-resistant urinary tract infection affected by Escherichia coli clonal group composition.
Smith SP; Manges AR; Riley LW
Clin Infect Dis; 2008 Mar; 46(5):689-95. PubMed ID: 18230040
[TBL] [Abstract][Full Text] [Related]
36. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
[TBL] [Abstract][Full Text] [Related]
37. Comparison of minimum inhibitory concentration values for fluoroquinolones against Escherichia coli causing urinary tract infection in both hospitalized patients and outpatients.
Tayfour M; Yuce A; Yulug N
Saudi Med J; 2001 Oct; 22(10):848-51. PubMed ID: 11744939
[TBL] [Abstract][Full Text] [Related]
38. Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis.
Gupta K; Hooton TM; Stamm WE
J Antimicrob Chemother; 2005 Jul; 56(1):243-6. PubMed ID: 15911548
[TBL] [Abstract][Full Text] [Related]
39. Active surveillance of antibiotic resistance prevalence in urinary tract and skin infections in the outpatient setting.
Kronenberg A; Koenig S; Droz S; Mühlemann K
Clin Microbiol Infect; 2011 Dec; 17(12):1845-51. PubMed ID: 21880098
[TBL] [Abstract][Full Text] [Related]
40. Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections.
Can F; Azap OK; Seref C; Ispir P; Arslan H; Ergonul O
Clin Infect Dis; 2015 Feb; 60(4):523-7. PubMed ID: 25378460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
